4202 Stock Overview
Engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,626.50 |
| 52 Week High | JP¥1,640.00 |
| 52 Week Low | JP¥1,126.00 |
| Beta | 0.62 |
| 1 Month Change | 17.01% |
| 3 Month Change | 13.11% |
| 1 Year Change | 38.43% |
| 3 Year Change | 88.47% |
| 5 Year Change | 71.21% |
| Change since IPO | 166.64% |
Recent News & Updates
Investors Don't See Light At End Of Daicel Corporation's (TSE:4202) Tunnel
May 02
Daicel's (TSE:4202) Dividend Will Be ¥25.00
Mar 27Shareholder Returns
| 4202 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 2.4% | -0.6% | 0.4% |
| 1Y | 38.4% | 20.9% | 24.2% |
Return vs Industry: 4202 exceeded the JP Chemicals industry which returned 20.9% over the past year.
Return vs Market: 4202 exceeded the JP Market which returned 24.2% over the past year.
Price Volatility
| 4202 volatility | |
|---|---|
| 4202 Average Weekly Movement | 4.2% |
| Chemicals Industry Average Movement | 3.9% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.0% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4202 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4202's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,207 | Yoshimi Ogawa | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors.
Daicel Corporation Fundamentals Summary
| 4202 fundamental statistics | |
|---|---|
| Market cap | JP¥448.61b |
| Earnings (TTM) | JP¥55.83b |
| Revenue (TTM) | JP¥558.06b |
8.0x
P/E Ratio0.8x
P/S RatioIs 4202 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4202 income statement (TTM) | |
|---|---|
| Revenue | JP¥558.06b |
| Cost of Revenue | JP¥398.78b |
| Gross Profit | JP¥159.28b |
| Other Expenses | JP¥103.45b |
| Earnings | JP¥55.83b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 202.43 |
| Gross Margin | 28.54% |
| Net Profit Margin | 10.01% |
| Debt/Equity Ratio | 80.0% |
How did 4202 perform over the long term?
See historical performance and comparison